Using virtual darkness to reduce agitation in dementia patients
Official title: Virtual Darkness and Digital Phenotyping in Specialized and Municipal Dementia Care: The DARK.DEM Randomized Controlled Trial
Run by University of Bergen · NCT06451952 · Data updated 2026-11-12
This study is testing if using virtual darkness can help reduce agitation in people with dementia.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 50 Years and up |
| Sex | All |
| Enrollment | 72 (estimated) |
| Sponsor | University of Bergen Academic / other |
| Locations | 1 site (Askøy, Erdal) |
| Status | Recruiting |
| Started | September 30, 2024 |
| Main results expected | December 31, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | October 21, 2026 |
| Trial ID | NCT06451952 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients aged 50 and older, diagnosed with dementia of any stage, who exhibit clinically significant agitation.
✕Probably not a fit
Patients who are totally blind or have significant pain may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This trial investigates the effectiveness of virtual darkness therapy as an adjunctive treatment for agitation in patients with dementia. It aims to develop digital phenotyping by comparing smartwatch data with established psychometric scales for behavioral and psychological symptoms of dementia (BPSD). The study will involve a randomized controlled trial with at least 72 patients, assessing the feasibility and safety of this innovative approach in a gerontopsychiatric hospital setting. The goal is to enhance treatment options for agitation, which is often resistant to conventional therapies.
Why it matters
Potential benefit: If successful, this therapy could provide a novel, non-pharmacological option to alleviate agitation in dementia patients, improving their quality of life.
How similar studies have gone: While some studies have shown positive effects of light therapy on BPSD, the use of virtual darkness as a treatment approach is relatively novel and untested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients refered to NKS Olaviken gerontopsychiatric hospital, both in and outpatient services * Diagnosis of dementia, all stages and etiologies, * ≥50 years * both genders * Clinically significant agitation (CMAI ≥45) Exclusion Criteria: * Total blindness/diminished bilateral red reflex. * Use of melatonin * Clinically significant pain (MOBID-2≥3)
Where it's running
-
NKS Olaviken Gerontopsychiatric Hospital
Askøy, Erdal, Norway Recruiting
Study contacts
- Study coordinator: Line Iden Berge, M.D., PhD.
- Email: line.berge@uib.no
- Phone: +4798857354
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
How flour milling methods affect blood sugar and gut feelings after eating bread
In healthy adults who eat bread regularly, this study tests whether bread made from stone-milled flour leads to a smaller rise in blood sugar and fewer gut symptoms than bread made from roller-milled flour.
-
Adapted acute abdomen guidelines for primary care in Zambia
This project tests whether adapting a high-income country guideline for acute abdomen to Zambia and implementing it in primary care can change how long patients stay in the hospital.
-
Group Unified Protocol therapy at a university outpatient clinic
This project will try group-based Unified Protocol therapy for adults 18–40 with anxiety or unipolar depression to see if it reduces symptoms and improves emotion regulation and well‑being.
-
Proactive phone calls to Norsk Rikstoto customers to reduce risky gambling
This trial tests whether a proactive, motivational phone call to Norsk Rikstoto customers aged 18–50 who show recent high-risk gambling can help them lower their losses and betting.
-
Using digital tools to monitor dementia with Lewy bodies
This study is testing new digital tools to help track changes in symptoms for people with dementia with Lewy bodies, so they can manage their condition better from home.
-
Assessing plaque burden and ischemia in patients with MINOCA
This study is testing how much plaque and inflammation is in the arteries of people who have had a heart attack but don’t have blocked arteries, to better understand their condition and improve treatment options.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.